NeueHealth, Inc.: Nasdaq/NYSE listing notice — Bright Health Group receives NYSE delisting notice for sub-$1 share price

NeueHealth, Inc.

NYSE notified BHG on Dec 6, 2022 that average closing price was below $1.00 for 30 trading days ending Dec 2, 2022.
Company has six months to regain compliance; considering reverse stock split subject to shareholder approval.
Stock continues trading on NYSE during cure period; no impact on operations or debt obligations.
If not cured, NYSE will suspend and delist BHG common stock.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

NeueHealth, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

December 6, 2022, Bright Health Group, Inc. (the “Company”), received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”), as the average closing price of the Company’s common stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period ending December 2, 2022. The Notice has no immediate impact on the listing of the Company’s Common Stock on the NYSE, subject to the Company’s compli

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001671284-22-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.